NCT07047924View on ClinicalTrials.gov

A Clinical Trial Assessing the Safety and Effectiveness of Orthokeratology Lenses in Patients With Myopia and Myopic Astigmatism

NANot yet recruitingINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions

MyopiaMyopic Astigmatism

Interventions

DEVICE

MCOK-01

The investigational device is a Rigid Gas Permeable contact lenses for orthokeratology. MCOK-01 applied the reverse geometry design and adopted the lens material which possesses the highest oxygen permeability among all the materials for orthokeratology lens.

Trial Locations (4)

2036

Eyecare Kids, Hillsdale

2052

UNSW School of Optometry and Vision Science, Sydney

3053

The University of Melbourne Department of Optometry and Vision Sciences, Carlton

4059

Queensland University of Technology Optometry and Vision Science, Kelvin Grove

All Listed Sponsors

lead

Menicon Co., Ltd.

INDUSTRY

NCT07047924 - A Clinical Trial Assessing the Safety and Effectiveness of Orthokeratology Lenses in Patients With Myopia and Myopic Astigmatism | Biotech Hunter | Biotech Hunter